Program overview
Context
Indication: Blastic Plasmacytoid Dendritic Cell Neoplasm
Mechanism: Unknown
Modality: Unknown
Sponsor: AbbVie
Timeline Staleness Signal
IMGN632
IMGN632 is flagged as timeline staleness signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 1/5
Timeline: 3/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT03386513
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT03386513 | Low Signal (ACTIVE_NOT_RECRUITING) | stale_update_signal | primary_completion_date_past_signal | long_recruitment_duration_signal | Low Signal | strict_eligibility_signal |